Infectious diseases in gynecologic oncology: an overview.

Area of Science:

• Gynecologic Oncology
• Infectious Diseases
• Oncology Therapeutics

Background:

• Multimodal therapeutic approaches are increasingly common in gynecologic oncology.
• These complex treatments alter the landscape of infectious diseases, affecting their nature, frequency, and presentation.
• Despite advances in diagnostics, surgery, and prophylactic antibiotics, infectious complications remain a significant cause of morbidity and mortality.

Purpose of the Study:

• To highlight the impact of evolving gynecologic oncology treatments on infectious disease patterns.
• To emphasize the need for strategic resource allocation and risk factor recognition in managing infections.
• To underscore the importance of understanding host-cancer interactions for infection prevention and treatment.

Main Methods:

• Review of current trends in gynecologic oncology treatment modalities.
• Analysis of the changing epidemiology of infectious diseases in this patient population.
• Evaluation of existing diagnostic, surgical, and prophylactic strategies.

Main Results:

• Infectious complications continue to pose significant challenges despite therapeutic advancements.
• A multimodal approach necessitates a re-evaluation of infection prevention and management strategies.
• Host-cancer interactions play a crucial role in susceptibility and response to infections.

Conclusions:

• Rational use of treatment resources and enhanced awareness of risk factors are essential for reducing infectious complications.
• Improved prevention and efficient treatment of infections are critical for better patient prognosis.
• Effective infection management in gynecologic oncology patients has substantial economic benefits.